Lu Gao

Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Immune resistance in hepatobiliary and pancreatic cancers: rethinking the tumor microenvironment beyond checkpoint blockade.

Immune resistance in hepatobiliary and pancreatic cancers: rethinking the tumor microenvironment beyond checkpoint blockade.

Journal: Frontiers in immunology
Published: May 01, 2026

Association of indocyanine green fluorescence navigation with extrahepatic biliary anatomy identification and operative efficiency in laparoscopic cholecystectomy: a retrospective cohort study.

Association of indocyanine green fluorescence navigation with extrahepatic biliary anatomy identification and operative efficiency in laparoscopic cholecystectomy: a retrospective cohort study.

Journal: Frontiers in medicine
Published: April 30, 2026

Hepatobiliary surgery in the era of immunotherapy: integrating surgical timing, immune surveillance, and recurrence prevention.

Hepatobiliary surgery in the era of immunotherapy: integrating surgical timing, immune surveillance, and recurrence prevention.

Journal: Frontiers in immunology
Published: April 26, 2026

Case report: How I do it? Laparoscopic hepatectomy with transcatheter arterial ICG staining for hepatolithiasis review.

Case report: How I do it? Laparoscopic hepatectomy with transcatheter arterial ICG staining for hepatolithiasis review.

Journal: Frontiers in medicine
Published: July 25, 2024

Sex - a potential factor affecting immune checkpoint inhibitor therapy for cancers.

Sex - a potential factor affecting immune checkpoint inhibitor therapy for cancers.

Journal: Frontiers in immunology
Published: August 21, 2022

Trans-arterial positive ICG staining-guided laparoscopic liver watershed resection for hepatocellular carcinoma.

Trans-arterial positive ICG staining-guided laparoscopic liver watershed resection for hepatocellular carcinoma.

Journal: Frontiers in oncology
Published: June 11, 2022

The role of complement in the clinical course of hepatocellular carcinoma.

The role of complement in the clinical course of hepatocellular carcinoma.

Journal: Immunity, inflammation and disease
Published: August 30, 2021

MiR-369-5p inhibits the proliferation and migration of hepatocellular carcinoma cells by down-regulating HOXA13 expression.

MiR-369-5p inhibits the proliferation and migration of hepatocellular carcinoma cells by down-regulating HOXA13 expression.

Journal: Tissue & cell
Published: July 06, 2021

The role of CpG island methylator phenotype in the clinical course of hepatocellular carcinoma.

The role of CpG island methylator phenotype in the clinical course of hepatocellular carcinoma.

Journal: Bioinformatics (Oxford, England)
Published: February 01, 2021

A Prognostic Model Based on RNA Binding Protein Predicts Clinical Outcomes in Hepatocellular Carcinoma Patients.

A Prognostic Model Based on RNA Binding Protein Predicts Clinical Outcomes in Hepatocellular Carcinoma Patients.

Journal: Frontiers in oncology
Published: October 01, 2020
Showing 1-10 of 10

Last Updated: 09/26/2026